Frost & Sullivan Research Service   Published: 10 Aug 2012
The Pharmaceutical Industry in Ethiopia
  SERVICE HOMEPAGE
RESEARCH OVERVIEW TABLE OF CONTENTS FURTHER INFORMATION
   Research Overview
 

This Frost & Sullivan research service titled The Pharmaceutical Industry in Ethiopia provides insights on the current market and its future growth areas. It also highlights key opportunities in each of six major therapeutic segments.

This analysis is available through our Life Sciences Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth. For more information on this custom subscription service, please click here.

Key Questions this Study Will Answer

  • How is the health care in Ethiopia structured? What regulations govern the pharmaceutical industry and how will these regulations impact the market in the future?
  • What is the size and growth potential of the pharmaceutical industry in Ethiopia? What are the drivers, restraints, and challenges within the industry?
  • What is the size and growth potential of various therapeutic segments in the pharmaceutical industry?
  • What opportunities exists for each of these segments?
  • Who are the existing competitors in the Ethiopian pharmaceutical industry and how is their marketing strategy structured to meet basic customer needs?
  • Who are the various competitors of the various therapeutic segments in the industry? How is the market divided amongst these competitors?
  • What factors contribute to the key growth opportunities in each therapeutic segment and what strategic recommendations can assist participants to capitalize on those opportunities?

Market Sectors:

  • Anti-infectives
  • Cardiovascular
  • Diabetes
  • Respiratory
  • Central nervous system
  • Oncology

  Table Of Contents

1. Executive Summary

2. Market Overview

3. Total Pharmaceutical Industry

   3.1 External Challenges: Drivers and Restraints

   3.2 Forecasts and Trends

   3.3 Market Share and Competitive Analysis

   3.4 Mega Trends and Industry Convergence Implications

4. The CEO’s 360-Degree Perspective

5. Anti-Infectives Therapeutic Segment Breakdown

6. Cardiovascular Therapeutic Segment Breakdown

7. Diabetes Therapeutic Segment Breakdown

8. Respiratory Therapeutic Segment Breakdown

9. Central Nervous System Therapeutic Segment Breakdown

10. Oncology Therapeutic Segment Breakdown

11. The Last Word (Conclusions and Implications)

12. Appendix



  Further Information

Enquiries from:
Africa:
Tel: +27 21 680 3260
Email: enquiries@frost.com
Enquiries from:
Asia Pacific:
Tel: +65 68900999
Email: apacfrost@frost.com
 
Enquiries from:
Europe:
Tel: +44 (0) 20 7343 8383
Email: enquiries@frost.com
Enquiries from:
Israel:
Tel: +972-9-9502888
Email: israel@frost.com
 
Enquiries from:
Latin America:
Tel: +54 11 4777 1550
Email: myfrost.la@frost.com
Enquiries from:
Middle East and North Africa:
Tel: +971.4.4331.893
Email: meenquiries@frost.com
 
Enquiries from:
North America:
Tel: +1.877.GO.FROST (463.7678)
Email: myfrost@frost.com
Enquiries from:
South Asia:
Tel: +91 (0) 22 6160 6666
Email: saenquiries@frost.com
 
For a full list of our offices click here.

Conseq